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so that the deployments could not be seen without fluo-
roscopy. A Philips V3000 angiography (Philips Medical
Systems Nederland BV, Eindhoven, Netherlands) machine
was used as a means of guiding and filming the endograft
deployments.
Each Slimgraft was introduced into the water flow
model through a 9F vascular sheath (Cook). The Wallstent
was then advanced over the guidewire and deployed inside
the graft. A bend made near the end of the guidewire per-
mitted the Wallstent to be deployed beyond the graft. The
stent then held the graft in place against the inner wall of
the tubing in the flow model.
A 5F Rosch celiac one catheter (Cook) was advanced
over the guidewire until it reached the suture that con-
nected the guidewire to the graft material. Then, counter-
traction was applied as the catheter was advanced. This
broke the thread without displacing the graft material.
The freed guidewire and the catheter were then removed,
leaving the endovascular graft in place.
In vivo study. All procedures were approved by the
Animal Care Committee and followed the American Heart
Association guidelines for animal research. Pigs were selected
for the animal model in this study because of the similarity of
their hemostatic and cardiovascular systems to those of
humans. Each pig weighed 30 kg (± 2 kg). Small pigs were
used to minimize costs and to facilitate fluoroscopy. The pig
femoral artery lies beneath several centimeters of muscle. For
this reason, a surgical cutdown was performed. After the
artery was exposed, a vascular introducer sheath was inserted.
Endovascular grafts that were 10 mm in diameter were
placed in four healthy pigs and five pigs with abdominal aor-
tic aneurysms. Aneurysms were created with the method of
Michael Hallisey.1 After initial aortography, Palmaz P308
stents were deployed in the infrarenal abdominal aorta. The
stents were dilated until the diameter of the stented portion
of the aorta was 11⁄2 times its earlier diameter. Aortography
was performed after abdominal aortic aneurysm creation 
(Fig 1). Four weeks after aneurysm creation, an endograft
In this article we describe a method for assembling an
endovascular graft within the aorta, with the graft and the
stent introduced as separate components. The compo-
nents are introduced individually and sequentially over a
guidewire. This significantly decreases the diameter of the
introducers needed for aortic endovascular graft place-
ment and may decrease the complications associated with
the procedure. The objective of this study was to test the
feasibility of this approach and to perform initial in vivo
studies on its safety and short-term effectiveness.
MATERIALS AND METHODS
Ex vivo study. The endovascular graft (Slimgraft) was
constructed from a Wallstent (Schneider, Plymouth, Minn)
that was 70 mm long and 24 mm wide and ultrathin polyester
fiber (Dacron) that was 50 υm thick. The Dacron was formed
into a tube graft that was 27 mm in diameter and 
75 mm in length. Each graft was sutured to the end of a 0.035
Amplatz ultrastiff guidewire (Cook, Bloomington, Ind).
Five Slimgrafts were deployed in a water flow model.
The water flow model into which each endovascular graft
was introduced consisted of a pump that circulated water
in a continuous stream at a rate of 17 L per minute
through transparent plastic tubing with a 3⁄4-in (19-mm)
internal diameter. The tubing was wrapped in bed sheets
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In this article we describe a method for assembling an endovascular graft within the aorta with a graft and then a stent
introduced sequentially over a guidewire as separate components. In the ex vivo study, an endovascular graft that was
25 mm in diameter was introduced through a 9F introducer. In the in vivo study, smaller endovascular grafts were
placed in the aortas of four healthy pigs and five pigs with aortic aneurysms. Our data suggest that this very low pro-
file system may have significant clinical implications because it converts aortic repair into a percutaneous procedure. (J
Vasc Surg 2001;34:350-2.)
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(consisting of a Dacron graft that was 10 mm in diameter by
40 mm in length and a Wallstent that was 10 mm in diame-
ter by 39 mm in length) was deployed to exclude the
aneurysm from the circulation (Fig 2). Four weeks after
endograft deployment, each animal was restudied and then
killed. All animals were given one clopidogrel tablet (75 mg)
in their food the day before endovascular graft implantation
and daily thereafter.
After the animals were killed, the stented segments of
the aorta were explanted and placed in 10% formalin. Each
specimen was cut into 3- to 4-mm thick cross sections
with wire cutting shears. Each cross section was examined
grossly with the aid of magnification, and each series of
cross sections was photographed. The proximal and distal
anastomotic segments were closely examined for disconti-
nuities between the graft and the native aortic wall.
RESULTS
Ex vivo study
An 80% (4 of 5) success rate was obtained. Five aortic
endografts were deployed in a water flow model with flu-
oroscopic guidance. In the first deployment, the guidewire
was released from the graft material without first advanc-
ing a diagnostic catheter over the wire to hold the graft in
place. The traction of the wire caused mild deformity of
the Wallstent. The first deployment was otherwise suc-
cessful. The four subsequent in vitro deployments were
completely successful.
Fig 2. Completion angiogram shows exclusion of aneurysm
without evidence of endoleak.
Fig 3. Cross sections of aortic aneurysms 1 month after Slimgraft
placement. Arrows indicate thrombus between endograft and 
vessel wall.
Fig 1. Angiogram performed immediately after creation of
abdominal aortic aneurysm. Palmaz P308 stent was expanded to
a diameter 50% larger than diameter of normal aorta.
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In vivo study
There were no acute complications or angiographic
evidence of acute thrombosis. In all cases, the aorta was
found to be patent by means of angiography 1 month after
endograft placement. In no animal was there angiographic
evidence of endoleak or movement of the endograft.
Healthy animals. Cross sections of all five formalin-
fixed stented aortic segments showed patent grafts with
lumina larger than the nonstented proximal and distal
aorta. In each case, a layer of clot was present between the
graft and the native aorta. All distal and proximal anasto-
moses were healed without evidence of leak.
Aneurysm model. Cross sections of all five formalin-
fixed stented aortic aneurysm segments (Fig 3) showed
patent grafts with lumina greater than or equal to the non-
stented, nonaneurysmal proximal and distal aorta. In each
case, a layer of clot was present between the graft and the
aneurysmal aortic wall. The thickness of this layered clot
was larger than that seen in the four nonaneurysmal
stented aortas. The anastomosis appeared healed, without
evidence of a leak. There were no signs of tears, jet lesions,
or flaps at the proximal or distal junctions.
DISCUSSION
The data presented here demonstrate that an aortic
endovascular graft can be assembled from its components
ex vivo and in vivo with fluoroscopic guidance and that it
can be used to successfully treat an aortic aneurysm model.
In vitro tests of two earlier Slimgraft prototypes have
been published.2,3 The earlier prototypes were deployed
with direct vision and no fluoroscopy.
Problems that must be addressed include decreasing
the introducer diameter to diagnostic catheter dimensions,
making the device easy to use, and the development of a
bifurcated graft. In this study, the endovascular graft was
assembled from one piece of graft material and one stent.
In the future, it should be possible to introduce the graft
in two or more separate thin layers. Instead of one stent,
it should be possible to introduce two or more thinner
stents. The combined layers of graft material and stents
could provide any thickness of graft and any stent radial
force desired. The components could be placed one
behind the other around the guidewire in the endovascu-
lar graft introducer. The leading edge of each component
could be loaded inside the trailing edge of the one ahead
of it. Deploying the device will be like closing a folding
telescope. Thin springs may be sutured to the grafts to
open them. The grafts may be folded so that blood flow
will open them just like wind opens flags and parachutes.
Assembling the Slimgraft in vivo involves more steps
than deploying other endovascular grafts. However, well-
designed Slimgraft introduction sets should make deploy-
ment easy.
In conclusion, the development of this very low pro-
file system may have significant clinical implications by
making aortic repair possible as a percutaneous procedure.
Patients treated with this device may have fewer local com-
plications than patients treated with current endografts.
We believe that clinical investigation is warranted.
We thank Mr Tom Roberts of the Boston Scientific
Corporation for the Wallstents and other items used in this
study and the Cordis Corporation for the Palmaz Stents
and angioplasty catheters used in this study.
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